Collagen matrix scaffold as vehicle of WP1066, STAT-3 inhibitors, in an in vitro hepatocellular model.

Introduction and objectives: Liver disease causes approximately 1.75 million deaths per year and chronic liver disease (CLD) and is usually detected in advanced stages (cirrhosis or hepatocellular carcinoma) that require partial ablation or transplant. STAT-3 has been identified as a therapeutic tar...

Full description

Bibliographic Details
Main Authors: Moises Martinez-Castillo, Cristina Piña-Barba, Israel A. Núñez-Tapia, Marisela Hernandez-Santillan, Abigail Hernández-Barragán, Gabriela Gutiérrez-Reyes
Format: Article
Language:English
Published: Elsevier 2024-02-01
Series:Annals of Hepatology
Online Access:http://www.sciencedirect.com/science/article/pii/S1665268124001972